IL160968A0 - Pharmaceutical compositions comprising mycophenolic acid or mycophenolate salt - Google Patents

Pharmaceutical compositions comprising mycophenolic acid or mycophenolate salt

Info

Publication number
IL160968A0
IL160968A0 IL16096802A IL16096802A IL160968A0 IL 160968 A0 IL160968 A0 IL 160968A0 IL 16096802 A IL16096802 A IL 16096802A IL 16096802 A IL16096802 A IL 16096802A IL 160968 A0 IL160968 A0 IL 160968A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
mycophenolic acid
mycophenolate salt
mycophenolate
salt
Prior art date
Application number
IL16096802A
Other languages
English (en)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9924043&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL160968(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of IL160968A0 publication Critical patent/IL160968A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
IL16096802A 2001-10-17 2002-10-16 Pharmaceutical compositions comprising mycophenolic acid or mycophenolate salt IL160968A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0124953.1A GB0124953D0 (en) 2001-10-17 2001-10-17 Organic Compounds
PCT/EP2002/011589 WO2003032978A1 (en) 2001-10-17 2002-10-16 Pharmaceutical compositions comprising mycophenolic acid or mycophenolate salt

Publications (1)

Publication Number Publication Date
IL160968A0 true IL160968A0 (en) 2004-08-31

Family

ID=9924043

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16096802A IL160968A0 (en) 2001-10-17 2002-10-16 Pharmaceutical compositions comprising mycophenolic acid or mycophenolate salt
IL160968A IL160968A (en) 2001-10-17 2004-03-18 Pharmaceutical preparations containing mycophenolic acid or mycophenolate salt

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL160968A IL160968A (en) 2001-10-17 2004-03-18 Pharmaceutical preparations containing mycophenolic acid or mycophenolate salt

Country Status (32)

Country Link
US (3) US20050013859A1 (xx)
EP (1) EP1438040B2 (xx)
JP (2) JP2005508959A (xx)
KR (1) KR100671367B1 (xx)
CN (1) CN1310640C (xx)
AR (2) AR036813A1 (xx)
AT (1) ATE374023T1 (xx)
AU (1) AU2002338897B2 (xx)
BR (1) BR0213355A (xx)
CA (1) CA2460574A1 (xx)
CO (1) CO5390076A1 (xx)
CY (1) CY1107841T1 (xx)
DE (1) DE60222687T3 (xx)
DK (1) DK1438040T4 (xx)
EC (2) ECSP024341A (xx)
ES (1) ES2292819T5 (xx)
GB (1) GB0124953D0 (xx)
HK (1) HK1067861A1 (xx)
HU (1) HU231114B1 (xx)
IL (2) IL160968A0 (xx)
MX (1) MXPA04003636A (xx)
MY (1) MY139206A (xx)
NO (1) NO341804B1 (xx)
NZ (1) NZ532280A (xx)
PE (1) PE20030476A1 (xx)
PL (2) PL415001A1 (xx)
PT (1) PT1438040E (xx)
RU (2) RU2338528C2 (xx)
SI (1) SI1438040T2 (xx)
TW (1) TWI333861B (xx)
WO (1) WO2003032978A1 (xx)
ZA (1) ZA200401977B (xx)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0124953D0 (en) 2001-10-17 2001-12-05 Novartis Ag Organic Compounds
AR045957A1 (es) * 2003-10-03 2005-11-16 Novartis Ag Composicion farmaceutica y combinacion
EP1699773A2 (en) * 2004-07-20 2006-09-13 Ceva Gyogyszergyar R Szv Nytarsasag Processes for preparation of crystalline mycophenolate sodium
GB0419355D0 (en) * 2004-08-31 2004-09-29 Novartis Ag Organic compounds
US20060235070A1 (en) * 2005-02-08 2006-10-19 Hayden Michael R Compositions and methods for treating vascular, autoimmune, and inflammatory diseases
US20060235009A1 (en) * 2005-02-08 2006-10-19 Richard Glickman Treatment of vascular, autoimmune and inflammatory diseases using low dosages of IMPDH inhibitors
KR20080064961A (ko) * 2005-09-30 2008-07-10 노파르티스 아게 자가면역 질환 및 이식편 거부반응의 치료에 사용하기 위한ｄｐｐ ｉｖ 억제제
WO2007071580A1 (de) * 2005-12-21 2007-06-28 Basf Se Feinteiliges quervernetztes polyvinylpyrrolidon als tablettensprengmittel
BRPI0707739A2 (pt) * 2006-02-13 2011-05-10 Novartis Ag dosagem elevada de Ácido micofenàlico
KR101903781B1 (ko) 2007-06-06 2018-11-13 바스프 에스이 급속 붕해 정제의 제조를 위한 제약 제제
EP2164460B1 (de) 2007-06-06 2017-08-09 Basf Se Pharmazeutische formulierung für die herstellung von schnell zerfallenden tabletten
MX2010001711A (es) * 2007-08-13 2010-03-11 Panacea Biotec Ltd Composiciones de liberacion extendida que comprenden micofenolato sodico y procedimientos de las mismas.
JP2011513391A (ja) * 2008-03-05 2011-04-28 パナセア バイオテック リミテッド ミコフェノラートを含有する徐放性医薬組成物およびその方法
CA2729834A1 (en) * 2008-07-09 2010-01-14 Aspreva International Ltd. Formulations for treating eye disorders
US20110086102A1 (en) * 2009-10-13 2011-04-14 Teva Pharmaceutical Industries Ltd. Delayed release compositions
EP2488173A1 (en) * 2009-10-13 2012-08-22 Teva Pharmaceutical Industries Ltd. Delayed release compositions
WO2011051967A2 (en) * 2009-10-23 2011-05-05 Alkem Laboratories Ltd Pharmaceutical compositions comprising mycophenolate and processes for preparing thereof
GB201100786D0 (en) 2011-01-18 2011-03-02 Ems Sa Pharmaceutical compositions of immunosuppressants
CN102793658A (zh) * 2012-08-23 2012-11-28 无锡福祈制药有限公司 一种含有麦考酚酸或麦考酚酸盐的骨架型制剂及其包衣片
CN103845323B (zh) * 2012-11-30 2018-02-02 重庆华邦制药有限公司 麦考酚酸及其盐肠溶制剂和制备方法
WO2014167442A1 (en) 2013-03-26 2014-10-16 Wockhardt Limited Pharmaceutical compositions comprising mycophenolic acid or salts thereof
CN106727403A (zh) * 2017-01-03 2017-05-31 无锡福祈制药有限公司 一种麦考酚钠肠溶片及其制备方法
CN110662533A (zh) * 2017-03-13 2020-01-07 奥卡瓦制药公司 向非人哺乳动物递送霉酚酸活性剂的方法和组合物
JP7266616B2 (ja) 2018-06-14 2023-04-28 ポクセル 糖尿病の治療において使用するためのトリアジン誘導体を含むフィルムコーティング錠剤
RU2723255C2 (ru) * 2018-11-14 2020-06-09 Общество с ограниченной ответственностью "Изварино Фарма" Экструдат с микофенолятом натрия для получения пероральной твердой лекарственной формы
MX2023008907A (es) * 2021-01-28 2023-08-09 Priothera Sas Metodos de tratamiento con moduladores del receptor de esfingosina-1-fosfato (s1p).
WO2022250977A1 (en) * 2021-05-26 2022-12-01 The Texas A&M University System Biodegradable mucoadhesive pharmaceutical formulations and methods thereof
CN117442580B (zh) * 2023-12-21 2024-04-05 泊诺(天津)创新医药研究有限公司 一种高生物利用度麦考酚钠肠溶片及其制备方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1157099A (en) * 1966-09-27 1969-07-02 Ici Ltd Fermentation Process
GB1157100A (en) † 1966-09-27 1969-07-02 Ici Ltd Pharmaceutical Compositions
GB1203328A (en) * 1968-06-04 1970-08-26 Ici Ltd Pharmaceutical compositions
US3880995A (en) * 1973-05-14 1975-04-29 Lilly Co Eli Treatment of arthritis with mycophenolic acid and derivatives
JPS56127093A (en) * 1980-03-10 1981-10-05 Ajinomoto Co Inc Preparation of mycophenolic acid
US4959387A (en) * 1986-01-23 1990-09-25 Syntex (U.S.A.) Inc. Mycophenolic acid derivatives in the treatment of rheumatoid arthritis
US4725622A (en) * 1986-01-23 1988-02-16 Syntex (U.S.A.) Inc. Mycophenolic acid derivatives in the treatment of rheumatoid arthritis
US4748173A (en) * 1987-01-30 1988-05-31 Syntex (U.S.A.) Inc. Heterocyclic aminoalkyl esters of mycophenolic acid and derivatives thereof and pharmaceutical compositions
US4753935A (en) * 1987-01-30 1988-06-28 Syntex (U.S.A.) Inc. Morpholinoethylesters of mycophenolic acid and pharmaceutical compositions
US5177072A (en) * 1987-01-30 1993-01-05 Syntex (U.S.A.) Inc. Treatment of autoimmune inflammatory, and psoriatic diseases with heterocyclic aminoalkyl esters of mycophenolic acid and derivatives
WO1994012184A1 (en) * 1992-11-24 1994-06-09 Syntex (U.S.A.) Inc. Use of mycophenolic acid, mycophenolate mofetil or derivate thereof to inhibit stenosis
AU3178293A (en) * 1992-11-24 1994-06-22 Syntex (U.S.A.) Inc. Use of mycophenolic acid, mycophenolate mofetil or derivate thereof to inhibit stenosis
BR9405836A (pt) * 1993-02-26 1996-01-16 Procter & Gamble Forma de dosagem de bisacodil
US5651983A (en) * 1993-02-26 1997-07-29 The Procter & Gamble Company Bisacodyl dosage form for colonic delivery
US5656290A (en) * 1993-02-26 1997-08-12 The Procter & Gamble Company Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
US5843479A (en) * 1993-02-26 1998-12-01 The Procter & Gamble Company Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
US5455045A (en) * 1993-05-13 1995-10-03 Syntex (U.S.A.) Inc. High dose formulations
RO115412B1 (ro) * 1993-10-01 2000-02-28 Syntex Inc Compozitie farmaceutica si procedeu de obtinere a compozitiei farmaceutice
US5514663A (en) * 1993-10-19 1996-05-07 The Procter & Gamble Company Senna dosage form
JP3725542B2 (ja) * 1993-10-19 2005-12-14 大正製薬株式会社 ピコサルフェート剤形
US5482718A (en) * 1994-03-23 1996-01-09 Hoffmann-La Roche Inc. Colon-targeted delivery system
US5686106A (en) * 1995-05-17 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form for colonic delivery
ID18663A (id) * 1996-04-12 1998-04-30 Novartis Ag Komposisi farmasi berlapis enterik
AU4565000A (en) * 1999-05-10 2000-11-21 Novartis Ag Organic compounds
HUP9903226A2 (en) * 1999-09-23 2002-08-28 Gyogyszerki Process for producing mycophenolic acid and derivatives thereof
JP2003525052A (ja) * 2000-02-29 2003-08-26 バイオコン・インディア・リミテッド マイコフェノール酸の製造および精製
GB0124953D0 (en) 2001-10-17 2001-12-05 Novartis Ag Organic Compounds
GB0301259D0 (en) 2003-01-20 2003-02-19 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
ES2292819T3 (es) 2008-03-16
DE60222687D1 (de) 2007-11-08
US20050013859A1 (en) 2005-01-20
CY1107841T1 (el) 2013-06-19
WO2003032978A1 (en) 2003-04-24
HUP0600451A2 (en) 2006-09-28
MY139206A (en) 2009-08-28
CO5390076A1 (es) 2004-04-30
SI1438040T1 (sl) 2008-04-30
RU2338528C2 (ru) 2008-11-20
NO341804B1 (no) 2018-01-22
DK1438040T4 (da) 2020-01-27
NZ532280A (en) 2007-05-31
AR085778A2 (es) 2013-10-30
PL234541B1 (pl) 2020-03-31
CN1564684A (zh) 2005-01-12
DK1438040T3 (da) 2008-02-04
EP1438040B2 (en) 2019-10-16
ES2292819T5 (es) 2020-05-29
RU2381026C2 (ru) 2010-02-10
NO20041785L (no) 2004-05-03
HK1067861A1 (en) 2005-04-22
ECSP024342A (es) 2003-03-10
US20120237601A1 (en) 2012-09-20
GB0124953D0 (en) 2001-12-05
ATE374023T1 (de) 2007-10-15
IL160968A (en) 2016-04-21
PL415001A1 (pl) 2016-02-29
TWI333861B (en) 2010-12-01
DE60222687T2 (de) 2008-07-17
KR20050037409A (ko) 2005-04-21
EP1438040A1 (en) 2004-07-21
JP2009137996A (ja) 2009-06-25
CA2460574A1 (en) 2003-04-24
PL367738A1 (en) 2005-03-07
PE20030476A1 (es) 2003-07-30
MXPA04003636A (es) 2004-07-27
HU231114B1 (hu) 2020-09-28
RU2007130786A (ru) 2009-02-20
KR100671367B1 (ko) 2007-01-19
RU2004115332A (ru) 2005-04-20
SI1438040T2 (sl) 2020-02-28
EP1438040B1 (en) 2007-09-26
AR036813A1 (es) 2004-10-06
ZA200401977B (en) 2006-05-31
AU2002338897B2 (en) 2006-10-19
ECSP024341A (es) 2003-12-01
CN1310640C (zh) 2007-04-18
JP2005508959A (ja) 2005-04-07
US20100210717A1 (en) 2010-08-19
DE60222687T3 (de) 2020-03-05
PT1438040E (pt) 2008-01-02
BR0213355A (pt) 2006-05-23

Similar Documents

Publication Publication Date Title
HK1067861A1 (en) Pharmaceutical compositions comprising mycophenolic acid or mycophenolate salt
HK1072200A1 (en) Pro-micelle pharmaceutical compositions
EP1450824A4 (en) PHARMACEUTICAL COMPOSITION
GB0111597D0 (en) Pharmaceutical compositions
ZA200109236B (en) Pharmaceutical compositions of erythropoietin.
HUP0303163A3 (en) Tramadol-based pharmaceutical composition
GB0117057D0 (en) Pharmaceutical composition
EP1408896A4 (en) PHARMACEUTICAL COMPOSITION
GB0129117D0 (en) Pharmaceutical composition
HK1068277A1 (en) Pharmaceutical compositions comprising chelidonineor derivatives thereof
GB0116107D0 (en) Pharmaceutical composition
GB0104752D0 (en) Pharmaceutical compositions
GB0127805D0 (en) Pharmaceutical composition
IL158172A0 (en) Pharmaceutical compositions containing (-)-hydroxycitric acid
HUP0302531A3 (en) Pharmaceutical compositions containing citalopram
GB2382302B (en) Pharmaceutical compositions
GB0126732D0 (en) Pharmaceutical compositions
HU0103049D0 (en) Pharmaceutical composition
GB0125061D0 (en) Pharmaceutical composition
GB0101744D0 (en) Pharmaceutical compositions
GB0101743D0 (en) pharmaceutical compositions
GB0101058D0 (en) Pharmaceutical compositions
GB0121826D0 (en) Pharmaceutical compositions
HU0105050D0 (en) Pharmaceutical compositions
IL161956A0 (en) Pharmaceutical compositions containing 5-bisoprolol